A much-anticipated new potential drug for COPD moved a step closer to the market after Verona Pharma submitted its New Drug Application to the U.S. FDA, seeking approval of ensifentrine as a maintenance therapy. In the latest episode of Optimum Perspectives podcast, Eva Haas caught up with Chris Martin, Senior Vice President of Commercial, who […]
Is a world without disease possible? That was the question posed by a meeting held at The Royal Society of Medicine in London last month. I hate to be a killjoy – but the answer is ‘No’. A world without disease would be a world without death. I’m sure the organisers of the The World […]
One Nucleus’ On Helix Conference 2023, provided insight into the current climate for Biotech companies, including the international outlook, and what to expect in the future. The past few years have been tough for the international Biotech market, with funding, Brexit, new regulations, trade agreements and supply chain issues. Additionally, valuations have fallen and consequently […]
YOUNG biotech companies need “patient investors” with “deep pockets” to weather today’s financial storms, the head of Novo Holdings Seed Investments has told the Optimum Perspectives podcast. In an in-depth interview, Søren Møller said fledgling firms should accept it might be some time before investor confidence returns to the sector – and they need to […]
LET’S play a word association game. AI. Healthcare. Are you thinking what I’m thinking? If so, you‘re thinking about drug discovery. It is a very hot topic in pharma right now. Billions are being poured into efforts to use artificial intelligence (AI) to spot new drugs. And for good reason. ‘Traditional’ drug discovery methods are […]
